AZAD
AZAD continuously invests in API development working closely with all its partners worldwide. Our mandate is clear: develop high barrier, non infringing APIs in cGMP conditions. To date, AZAD has developed and participated in several court challenges resulting in increased revenues for our clients. In addition, AZAD entered into partnership with Yonsung Fine Chemicals of Korea in 2003 to distribute Latanoprost exclusively around the world. This partnership produced collaboration on all of Yonsung's additional APIs. On track with its goals, AZAD began partnering with proven European/Chinese/Indian companies for worldwide development, manufacturing and representation of APIs.
Last updated on